Fady Haddad

64PUBLICATIONS
97CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityPredictive and prognostic markersGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (64)

|Jul 15, 2026
Prevalence and Prognostic Impact of ASXL1 Somatic Mutation in Patients with Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis.

|May 28, 2026
Chronic myeloid leukemia: incorporation of recent advances into current treatment algorithms.

|May 17, 2026
Predictors of Relapse and Post-Relapse Outcomes After Frontline Blinatumomab in Philadelphia Chromosome-Negative B-ALL.

|May 06, 2026
Prognostic impact of ASXL1 mutations in acute myeloid leukemia treated with lower intensity therapy.

|Apr 14, 2026
Integrated Analysis of Genomics, Molecular Responses, and Outcomes of CBF-AML with FLAG-Based Therapy on a Phase II Trial.

Jayastu Senapati, Hagop M Kantarjian, Edward Ayoub

|Apr 09, 2026
Outcome of second-line therapy in adult B-cell acute lymphoblastic leukemia.

Hagop Kantarjian, Wei Qiao, Nitin Jain

Pageof 11

Frequent Collaborators

40 joint publications

Hagop M Kantarjian

37 joint publications

Elias Jabbour

33 joint publications

Nicholas J Short

28 joint publications

Tapan M Kadia